Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,297 GBX | -0.07% | +12.77% | +2.28% |
25/03 | Bioventix PLC Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
29/01 | Bioventix CEO Harrison sells GBP2.6 million in shares | AN |
Business Summary
Number of employees: 12
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sheep Monoclonal Antibodies
100.0
%
| 12 | 100.0 % | 13 | 100.0 % | +9.36% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of the World
80.0
%
| 10 | 82.0 % | 10 | 80.0 % | +6.72% |
European Union
12.5
%
| 1 | 11.3 % | 2 | 12.5 % | +20.86% |
United Kingdom
7.5
%
| 1 | 6.7 % | 1 | 7.5 % | +22.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Harrison
CEO | Chief Executive Officer | 65 | 23/03/23 |
Director of Finance/CFO | 65 | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 26/04/26 | |
Peter Harrison
CEO | Chief Executive Officer | 65 | 23/03/23 |
Nick McCooke
BRD | Director/Board Member | 71 | 25/14/25 |
Director of Finance/CFO | 65 | 01/20/01 | |
Joanne Pisani
BRD | Director/Board Member | 59 | 30/23/30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,219,656 | 4,800,925 ( 91.98 %) | 0 | 91.98 % |
Company contact information
Bioventix Plc
7 Romans Business Park East Street
GU9 7SX, Farnham
+44 12 5272 8001
http://www.bioventix.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.28% | 285M | |
+34.09% | 52.85B | |
-7.69% | 38.87B | |
+35.34% | 38.24B | |
-10.77% | 26.79B | |
+11.66% | 26.16B | |
-18.72% | 19.9B | |
+36.30% | 13.18B | |
+29.36% | 12.24B | |
-3.05% | 11.79B |
- Stock Market
- Equities
- BVXP Stock
- Company Bioventix PLC